v3.26.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ (456) $ 1 $ 691,095 $ 27 $ (691,579)
Beginning balance, shares at Dec. 31, 2024   80,099,889      
Exercise of stock options and release of RSUs, shares   521,404      
Stock-based compensation 2,008   2,008    
Other comprehensive income (loss) (28)     (28)  
Net Income (Loss) 23,525       23,525
Ending balance at Mar. 31, 2025 25,049 $ 1 693,103 (1) (668,054)
Ending balance, shares at Mar. 31, 2025   80,621,293      
Beginning balance at Dec. 31, 2024 (456) $ 1 691,095 27 (691,579)
Beginning balance, shares at Dec. 31, 2024   80,099,889      
Other comprehensive income (loss) 6        
Net Income (Loss) 23,371        
Ending balance at Jun. 30, 2025 119,910 $ 2 788,083 33 (668,208)
Ending balance, shares at Jun. 30, 2025   164,911,115      
Beginning balance at Mar. 31, 2025 25,049 $ 1 693,103 (1) (668,054)
Beginning balance, shares at Mar. 31, 2025   80,621,293      
Exercise of stock options and release of RSUs 76   76    
Exercise of stock options and release of RSUs, shares   332,741      
Issuance of common stock under the ESPP 101   101    
Issuance of common stock under the ESPP, shares   110,974      
Issuance of common stock in follow on offering, net of issuance cost 93,373 $ 1 93,372    
Issuance of common stock in follow on offering, net of issuance cost, shares   76,923,076      
Exercise of pre-funded warrants, shares   6,923,031      
Stock-based compensation 1,431   1,431    
Other comprehensive income (loss) 34     34  
Net Income (Loss) (154)       (154)
Ending balance at Jun. 30, 2025 119,910 $ 2 788,083 33 (668,208)
Ending balance, shares at Jun. 30, 2025   164,911,115      
Beginning balance at Dec. 31, 2025 99,008 [1] $ 2 810,844 111 (711,949)
Beginning balance, shares at Dec. 31, 2025   170,186,365      
Exercise of stock options and release of RSUs 281   281    
Exercise of stock options and release of RSUs, shares   1,516,946      
Issuance of common stock in follow on offering, net of issuance cost 228,351   228,351    
Issuance of common stock in follow on offering, net of issuance cost, shares   45,990,567      
Issuance of pre-funded warrants in follow on offering, net of issuance cost 5,855   5,855    
Stock-based compensation 4,706   4,706    
Other comprehensive income (loss) (9)     (9)  
Net Income (Loss) (18,248)       (18,248)
Ending balance at Mar. 31, 2026 319,944 $ 2 1,050,037 102 (730,197)
Ending balance, shares at Mar. 31, 2026   217,693,878      
Beginning balance at Dec. 31, 2025 99,008 [1] $ 2 810,844 111 (711,949)
Beginning balance, shares at Dec. 31, 2025   170,186,365      
Other comprehensive income (loss) (307)        
Net Income (Loss) (38,914)        
Ending balance at Jun. 30, 2026 302,068 $ 2 1,053,125 (196) (750,863)
Ending balance, shares at Jun. 30, 2026   217,899,284      
Beginning balance at Mar. 31, 2026 319,944 $ 2 1,050,037 102 (730,197)
Beginning balance, shares at Mar. 31, 2026   217,693,878      
Exercise of stock options and release of RSUs 265   265    
Exercise of stock options and release of RSUs, shares   125,074      
Issuance of common stock under the ESPP 246   246    
Issuance of common stock under the ESPP, shares   80,332      
Stock-based compensation 2,577   2,577    
Other comprehensive income (loss) (298)     (298)  
Net Income (Loss) (20,666)       (20,666)
Ending balance at Jun. 30, 2026 $ 302,068 $ 2 $ 1,053,125 $ (196) $ (750,863)
Ending balance, shares at Jun. 30, 2026   217,899,284      
[1] The condensed balance sheet as of December 31, 2025 was derived from the audited financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025.